Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 6
2008 11
2009 21
2010 23
2011 37
2012 52
2013 39
2014 25
2015 20
2016 28
2017 21
2018 22
2019 21
2020 15
2021 23
2022 16
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

339 results

Results by year

Filters applied: . Clear all
Page 1
Vandetanib.
Al-Ghusn AI, Bakheit AH, Attwa MW, AlRabiah H. Al-Ghusn AI, et al. Profiles Drug Subst Excip Relat Methodol. 2023;48:109-134. doi: 10.1016/bs.podrm.2022.11.004. Epub 2023 Feb 2. Profiles Drug Subst Excip Relat Methodol. 2023. PMID: 37061272 Review.
Vandetanib.
[No authors listed] [No authors listed] 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999926 Free Books & Documents. Review.
Vandetanib.
[No authors listed] [No authors listed] 2018 Jun 28. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 Jun 28. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643498 Free Books & Documents. Review.
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Wells SA Jr, Robinson BG, Gagel RF, Dralle H, Fagin JA, Santoro M, Baudin E, Elisei R, Jarzab B, Vasselli JR, Read J, Langmuir P, Ryan AJ, Schlumberger MJ. Wells SA Jr, et al. J Clin Oncol. 2012 Jan 10;30(2):134-41. doi: 10.1200/JCO.2011.35.5040. Epub 2011 Oct 24. J Clin Oncol. 2012. PMID: 22025146 Free PMC article. Clinical Trial.
Vandetanib photoinduced cutaneous toxicities.
Doan HQ, Hu MI, Goldstein J, Piha-Paul SA, Subbiah V, Patel AB. Doan HQ, et al. Cutis. 2019 May;103(5):E24-E29. Cutis. 2019. PMID: 31233590 Review.
Vandetanib.
Vozniak JM, Jacobs JM. Vozniak JM, et al. J Adv Pract Oncol. 2012 Mar;3(2):112-6. J Adv Pract Oncol. 2012. PMID: 25031937 Free PMC article. Review. No abstract available.
Vandetanib for the treatment of medullary thyroid carcinoma.
Cooper MR, Yi SY, Alghamdi W, Shaheen DJ, Steinberg M. Cooper MR, et al. Ann Pharmacother. 2014 Mar;48(3):387-94. doi: 10.1177/1060028013512791. Epub 2013 Nov 14. Ann Pharmacother. 2014. PMID: 24259657 Review.
Vandetanib: in medullary thyroid cancer.
Frampton JE. Frampton JE. Drugs. 2012 Jul 9;72(10):1423-36. doi: 10.2165/11209300-000000000-00000. Drugs. 2012. PMID: 22715896 Review.
Vandetanib as a potential treatment for breast cancer.
De Luca A, D'Alessio A, Maiello MR, Gallo M, Bevilacqua S, Frezzetti D, Morabito A, Perrone F, Normanno N. De Luca A, et al. Expert Opin Investig Drugs. 2014 Sep;23(9):1295-303. doi: 10.1517/13543784.2014.942034. Epub 2014 Aug 4. Expert Opin Investig Drugs. 2014. PMID: 25089348 Review.
339 results